Amgen Stock Analysis (NASDAQ:AMGN)

Add to My Stocks
$154.8 $1.32 (0.85%) AMGN stock closing price Jan 17, 2017 (Closing)
Watch Robo Advisor Video of AMGN Stock Analysis
Amgen
Updated on : Jan 17, 2017
previous close
AMGN 154.8 (0%)
S&P 500 2267.9 (0%)
Closing Price On: Jan 17, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
41.4%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
35.32B
Debt/Equity Ratio:
 1.15
Compared to the industry
Cash Flow
Operating cash flow:
$2.66B
Net Income:
$2.02B
Dividend Yield
AMGN dividend yield:
2.45%
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
FCF Margin
PE Valuation
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
AMGN PS :
5.1
Industry PS :
4.5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
25.3%
Return on Equity:
26%
Free Cash Flow Margin:
43%
Double Tap To Exit Full Screen
0:00
/

Amgen Analysis Video

847 5 3 1

View Amgen stock analysis video. This is our AMGN analyst opinion covering the buy and sell arguments for AMGN stock.

Amgen, Inc. Stock Rating (4.3/5)

Our Amgen stock opinion is based on fundamentals of the company. This Amgen stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy AMGN stock?

  • Amgen's average operating margin of 41.4% was exceptional.
  • LTM Net margins were good at 33.6% for Amgen.
  • AMGN stock is trading at an earnings multiple of 13.6 which is better than the industry average of 21.9.
  • Amgen generates a high return on invested capital of 25.3%.
  • Amgen has a good Return On Equity (ROE) of 26%.
  • The company has a healthy free cash flow margin of 43%.

Should you sell AMGN stock?

  • With a debt/equity ratio of  1.15, Amgen is highly leveraged in comparison to Medical peers.

Comments on this video and Amgen stock

tavern123 on Amgen stock analysis ($148.69)
bullish
The stock is relatively cheap. It deserves another look. If "what goes up, must come down", then "what is down, should go up"!
reply